Project Category : Oncology
LATEST INDUSTRY PROJECTS IN ONCOLOGY
Voreloxin, Anti-Cancer Quinolone Derivative
Voreloxin is a quinolone derivative being investigated for the...
Voreloxin is a quinolone derivative being investigated for the...
Xeloda – Treatment for Metastatic Colorectal Cancer
Xeloda is an approved oral drug developed by F. Hoffmann-La Roche...
Xeloda is an approved oral drug developed by F. Hoffmann-La Roche...
Stimuvax - Investigational Therapeutic Cancer Vaccine
Stimuvax, formerly known as BLP25 liposome vaccine (L-BLP25),...
Stimuvax, formerly known as BLP25 liposome vaccine (L-BLP25),...
- Abiraterone – Prostate Cancer Therapy,
- Avastin (bevacizumab) - Angiogenesis Inhibitor and Cancer Therapy,
- Blinatumomab - Treatment for Non-Hodgkin's Lymphoma and Acute Lymphoblastic Leukaemia,
- Cervarix – Cervical Cancer Vaccine,
- Dasatinib - Tyrosine Kinase Inhibitor for Chronic Myeloid Leukaemia (CML),
- Elotuzumab – Anti-CS1 Antibody for Multiple Myeloma,
- Erbitux (Cetuximab) - Biological Cancer Therapy,
- Hycamtin – Anti-Tumour Drug for Treatment of Relapsed Small Cell Lung Cancer,
- Ixempra (Ixapebilone) – New Cancer Therapy,
- KRX-0401 (Perifosine), Oral Anti-Cancer Treatment,
- Nexavar – Oral Anti-Cancer Agent for Treatment of Liver and Kidney Cancer,
- Pertuzumab –Cancer Therapy,
- Stimuvax - Investigational Therapeutic Cancer Vaccine,
- Tarceva - Small Molecule EGFR-Tyrosine Kinase Inhibitor for Cancer,
- Tasigna (Nilotinib) – Treatment for Philadelphia Chromosome Positive Chronic Myeloid Leukaemia, USA
- Tesmilifene - Chemopotentiator for Cancer Therapies,
- Trastuzumab - Treatment for HER2-Positive Advanced Recurrent Gastric Cancer, USA
- Tykerb - Dual Tyrosine Kinase Inhibitor for the Treatment of Solid Tumours,
- Voreloxin, Anti-Cancer Quinolone Derivative, USA
- Xeloda – Treatment for Metastatic Colorectal Cancer, USA
- Zactima - Tyrosine Kinase Inhibitor for Treatment of Lung Cancer,
